• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于健康志愿者中致幻剂诱发人格改变的急性生理和心理调节因素的调查。

An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.

作者信息

Godfrey Kate, Weiss Brandon, Zhang Xinhu, Spriggs Meg, Peill Joseph, Lyons Taylor, Carhart-Harris Robin, Erritzoe David

机构信息

Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, UK.

Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, MD, USA.

出版信息

Neurosci Appl. 2024 Dec 2;4:104092. doi: 10.1016/j.nsa.2024.104092. eCollection 2025.

DOI:10.1016/j.nsa.2024.104092
PMID:40654586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12244184/
Abstract

This study investigated the effects of a single high-dose of psilocybin on personality traits in psychedelic-naïve healthy volunteers. These data originate from a larger within-subjects fixed-order design trial, where a single high dose of psilocybin (25 mg) was administered in a psychologically supportive setting and was compared against a (one-month) prior, 1 mg 'placebo' dose. Personality shifts were assessed by the Big Five Inventory and the Big Five Aspect Scale, while the Altered States of Consciousness questionnaire (5D-ASC) and the Psychological Insight Scale gauged the acute psychological effects of the substance. Electroencephalography provided neurophysiological insights, specifically examining alpha power and Lempel-Ziv complexity (LZc). Results indicated significant reductions in neuroticism one month after 25 mg psilocybin administration, a finding consistent with prior studies. Reductions in neuroticism were moderated by the subjective meaningfulness of the psychedelic experience, as well as by the dread of ego dissolution subscale of the 5D-ASC, suggesting a relationship between acute drug effects and enduring personality alterations. Thus, this study substantiates the role of acute psychedelic states in catalysing lasting personality transformations in a generally beneficial direction, with broader implications for therapeutic applications and understanding of personality dynamics.

摘要

本研究调查了单次高剂量裸盖菇素对初次接触迷幻剂的健康志愿者人格特质的影响。这些数据源自一项更大规模的受试者内固定顺序设计试验,在该试验中,单次高剂量的裸盖菇素(25毫克)在心理支持环境下给药,并与之前(一个月前)的1毫克“安慰剂”剂量进行比较。人格变化通过大五人格量表和大五人格方面量表进行评估,而意识状态改变问卷(5D-ASC)和心理洞察力量表则衡量了该物质的急性心理效应。脑电图提供了神经生理学见解,特别检查了阿尔法波功率和莱姆佩尔-齐夫复杂度(LZc)。结果表明,服用25毫克裸盖菇素一个月后,神经质显著降低,这一发现与先前的研究一致。神经质的降低受到迷幻体验的主观意义以及5D-ASC中自我解体恐惧子量表的调节,表明急性药物效应与持久的人格改变之间存在关联。因此,本研究证实了急性迷幻状态在催化持久的人格转变方面所起的作用,这种转变总体上朝着有益的方向发展,对治疗应用和人格动力学的理解具有更广泛的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/12244184/d26a352c7a71/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/12244184/4077a26488b3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/12244184/96836dbb4543/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/12244184/498de3b272a0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/12244184/d26a352c7a71/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/12244184/4077a26488b3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/12244184/96836dbb4543/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/12244184/498de3b272a0/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa79/12244184/d26a352c7a71/gr4.jpg

相似文献

1
An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers.一项关于健康志愿者中致幻剂诱发人格改变的急性生理和心理调节因素的调查。
Neurosci Appl. 2024 Dec 2;4:104092. doi: 10.1016/j.nsa.2024.104092. eCollection 2025.
2
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
3
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
4
Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder.裸盖菇素辅助疗法可能提升酒精使用障碍患者的保护价值观。
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):31-40. doi: 10.1089/psymed.2024.0030. eCollection 2025 Mar.
5
The phenomenology of psilocybin's experience mediates subsequent persistent psychological effects independently of sex, previous experience, or setting.裸盖菇素体验的现象学独立于性别、既往经历或环境,介导后续持续的心理效应。
Pharmacol Rep. 2025 Jun 16. doi: 10.1007/s43440-025-00742-5.
6
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
7
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.左乙拉西坦添加治疗耐药性局灶性癫痫:Cochrane系统评价的更新版
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD001901. doi: 10.1002/14651858.CD001901.pub2.
8
Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials.一项为期两年的随访研究(PRIMROSE 3),旨在评估完成PRIMROSE 1和PRIMROSE 2林扎戈利克斯试验的子宫肌瘤患者的骨矿物质密度。
Hum Reprod Open. 2025 May 13;2025(3):hoaf025. doi: 10.1093/hropen/hoaf025. eCollection 2025.
9
Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled Trial.Rho相关激酶抑制剂NRL-1049在健康志愿者中的安全性、耐受性和药代动力学:一项1期、首次人体、单剂量递增、随机、安慰剂对照试验。
CNS Drugs. 2025 Jul 8. doi: 10.1007/s40263-025-01198-0.
10
Galantamine for Alzheimer's disease.加兰他敏用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2001(4):CD001747. doi: 10.1002/14651858.CD001747.

本文引用的文献

1
Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine.低剂量 LSD 后神经复杂性增加,但中高剂量口服 THC 或甲基苯丙胺则不会。
Neuropsychopharmacology. 2024 Jun;49(7):1120-1128. doi: 10.1038/s41386-024-01809-2. Epub 2024 Jan 29.
2
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.评估依他普仑与裸盖菇素治疗抑郁症试验中的期待和暗示性。
Psychol Med. 2024 Jun;54(8):1717-1724. doi: 10.1017/S0033291723003653. Epub 2024 Jan 22.
3
The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosing.
“安慰剂组”和“安慰剂对照”之间的区别:迷幻药微剂量的案例研究。
Sci Rep. 2023 Jul 26;13(1):12107. doi: 10.1038/s41598-023-34938-7.
4
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.抑郁症的迷幻蘑菇疗法与依地普仑治疗对照试验中的人格改变。
Psychol Med. 2024 Jan;54(1):178-192. doi: 10.1017/S0033291723001514. Epub 2023 Jun 2.
5
Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study.服用死藤水后心理健康、幸福感和人格的变化:一项自然主义纵向研究的结果。
Front Pharmacol. 2022 Oct 26;13:884703. doi: 10.3389/fphar.2022.884703. eCollection 2022.
6
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.迷幻疗法治疗抑郁症状:系统评价和荟萃分析。
J Affect Disord. 2023 Feb 1;322:194-204. doi: 10.1016/j.jad.2022.09.168. Epub 2022 Oct 7.
7
Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.裸盖菇素使用后状态焦虑和特质焦虑的降低:一项针对静修参与者的自然主义观察性研究。
Front Psychiatry. 2022 Jul 7;13:883869. doi: 10.3389/fpsyt.2022.883869. eCollection 2022.
8
Sustained effects of single doses of classical psychedelics in humans.人类单次摄入经典迷幻药的持续效应。
Neuropsychopharmacology. 2023 Jan;48(1):145-150. doi: 10.1038/s41386-022-01361-x. Epub 2022 Jun 21.
9
Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.治疗联盟与融洽关系调节对裸盖菇素辅助治疗抑郁症的反应。
Front Pharmacol. 2022 Mar 31;12:788155. doi: 10.3389/fphar.2021.788155. eCollection 2021.
10
Repeated low doses of LSD in healthy adults: A placebo-controlled, dose-response study.健康成年人中重复低剂量 LSD:一项安慰剂对照、剂量反应研究。
Addict Biol. 2022 Mar;27(2):e13143. doi: 10.1111/adb.13143. Epub 2022 Feb 1.